MSC to Produce Resin Modified Wood in North America Using Fibre7 Impregnation Process

Momentive Specialty Chemicals Inc., (“MSC”) has signed a licensing agreement with Fibre7 Limited, based in Wiltshire, United Kingdom, to produce and market resin modified wood in North America using Fibre7’s patented impregnation process.

Fibre7 manufactures LigniaTM and Lignia XDTM modified wood from plantation-grown, New Zealand radiata pine. Both wood products utilize resins supplied by MSC and are used in interior applications such as flooring, furniture and worktops (Lignia) and exterior applications such as decking, windows and doors (Lignia XD).

“Fibre7 is the first and only company to currently have a modified timber offering for internal and external use, which enables customers to match the color and durability characteristics throughout a project,” says Christopher Lusty, Chairman, Fibre7. “Wood dyes can be blended during the impregnation process to create unique color options in the wood for both internal and external applications.”

“We’re excited to partner with Fibre7 to help bring their innovative products to the North American market,” says Dale Plante, President, Forest Products Division, MSC. “The combination of their commercially viable impregnation process and our unique resin technology will create a successful partnership. The sustainable softwood used as the raw material is quick growing, Forest Stewardship Council certified and has a positive impact on global carbon dioxide emissions. Finally there is an alternative to tropical hardwoods.”

About Fibre7 Limited

Fibre7 Limited is a privately owned company that has commercialized the densification and coloring of managed plantation timber. Fibre7’s offices are in Wiltshire, England from where it supports its international customer base. The manufacturing plant is based in Tauranga on the East Coast of the North Island of New Zealand. Fibre7’s patented impregnation process enables it to sell plantation timber that has the properties of premium hardwood, but with added performance and color options.

About Momentive Specialty Chemicals, Inc.

Based in Columbus, Ohio, Momentive Specialty Chemicals Inc. (formerly known as Hexion Specialty Chemicals, Inc.) is the global leader in thermoset resins. Momentive Specialty Chemicals Inc. serves the global wood and industrial markets through a broad range of thermoset technologies, specialty products and technical support for customers in a diverse range of applications and industries. Momentive Specialty Chemicals Inc. is an indirect wholly owned subsidiary of Momentive Performance Materials Holdings LLC.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Momentive Performance Materials, Inc.. (2019, February 08). MSC to Produce Resin Modified Wood in North America Using Fibre7 Impregnation Process. AZoM. Retrieved on November 22, 2024 from https://www.azom.com/news.aspx?newsID=38844.

  • MLA

    Momentive Performance Materials, Inc.. "MSC to Produce Resin Modified Wood in North America Using Fibre7 Impregnation Process". AZoM. 22 November 2024. <https://www.azom.com/news.aspx?newsID=38844>.

  • Chicago

    Momentive Performance Materials, Inc.. "MSC to Produce Resin Modified Wood in North America Using Fibre7 Impregnation Process". AZoM. https://www.azom.com/news.aspx?newsID=38844. (accessed November 22, 2024).

  • Harvard

    Momentive Performance Materials, Inc.. 2019. MSC to Produce Resin Modified Wood in North America Using Fibre7 Impregnation Process. AZoM, viewed 22 November 2024, https://www.azom.com/news.aspx?newsID=38844.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.